清除令人困惑的混:奔二胺和痴呆的风险?
Kevin J Friesen1, Jamie Falk1, I Fan Kuo2
1College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
长期使用二甲可能不会显著增加痴呆症风险. 与其他健康状况一样的混因素似乎驱动了最初的关联,经过调整后的分析显示没有联系. 由于其他风险,建议谨慎使用.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 二甲类药物被广泛用于治疗焦虑和失眠.
- 人们担心潜在的长期认知影响,包括痴呆风险.
研究的目的:
- 调查二胺暴露的持续时间与患痴呆症的风险之间的关联.
- 确定混因素是否影响观察到的关系.
主要方法:
- 使用加拿大马尼托巴省行政卫生数据进行的回顾性队列研究.
- 对3个年龄层 (55,65,75) 到22岁的年龄层进行分析,通过累计定义每日剂量 (DDD) 量化使用二甲.
- 采用限制方法 (抑郁症/焦虑症) 和高维倾向得分 (HDPS) 匹配以控制混变量.
主要成果:
- 在最年轻的年龄层 (aHR 1.33) 的高剂量二胺使用者中观察到痴呆风险的适度增加.
- 这种关联在老年阶层中没有显著意义.
- 通过限制或HDPS匹配控制混因素 (例如糖尿病,心血管疾病,抑郁症,焦虑症) 消除了观察到的关联.
结论:
- bensodiazepine 使用与痴呆症风险之间的明显联系可能归因于并发性疾病的混.
- 二西平似乎不是痴呆症的重要独立风险因素.
- 尽管缺乏痴呆症的联系,但长期使用二二类药物需要谨慎,因为有耐受性,依赖性和不良影响的风险.
更多相关视频
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
